Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 1 (2004), Issue 4 (November)

1. Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases.
   Eur Respir J, 24(5): 814-21. [Abstract] [Full-text]
2. Type of wine and risk of lung cancer: a case-control study in Spain.
   Thorax, 59(11): 981-5. [Abstract] [Full-text]
3. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers.
   Int J Cancer, 113(1): 59-66. [Abstract] [Full-text]
4. CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans.
   Int J Cancer, 113(1): 141-7. [Abstract] [Full-text]
5. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
   Int J Cancer, 113(1): 101-8. [Abstract] [Full-text]
6. Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.
   Int J Cancer, 113(1): 109-15. [Abstract] [Full-text]
7. Downregulation of connexin 26 in human lung cancer is related to promoter methylation.
   Int J Cancer, 113(1): 14-21. [Abstract] [Full-text]
8. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.
   Virchows Arch, 445(5): 449-55. [Abstract] [Full-text]
9. Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells.
   J Biol Chem, 279(45): 46706-14. [Abstract] [Full-text]
10. Expression of occludin, a tight-junction-associated protein, in human lung carcinomas.
    Virchows Arch, 445(5): 472-6. [Abstract] [Full-text]
11. Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention.
    Cancer Res, 64(21): 8109-15. [Abstract] [Full-text]
12. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice.
    Cancer Res, 64(21): 7971-6. [Abstract] [Full-text]
13. Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase.
    Cancer Res, 64(21): 7852-6. [Abstract] [Full-text]
14. Profiling the evolution of human metastatic bladder cancer.
    Cancer Res, 64(21): 7813-21. [Abstract] [Full-text]
15. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer.
    Ann Oncol, 15(11): 1654-60. [Abstract] [Full-text]
16. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.
    Ann Oncol, 15(11): 1645-53. [Abstract] [Full-text]
17. Correlation of lung tumor motion with external surrogate indicators of respiration.
    Int J Radiat Oncol Biol Phys, 60(4): 1298-306. [Abstract] [Full-text]
18. Correlation of gross tumor volume excursion with potential benefits of respiratory gating.
    Int J Radiat Oncol Biol Phys, 60(4): 1291-7. [Abstract] [Full-text]
19. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer.
    Int J Radiat Oncol Biol Phys, 60(4): 1283-90. [Abstract] [Full-text]
20. A challenge to traditional radiation oncology.
    Int J Radiat Oncol Biol Phys, 60(4): 1241-56. [Abstract] [Full-text]
21. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
    Int J Radiat Oncol Biol Phys, 60(4): 1106-12. [Abstract] [Full-text]
22. Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial.
    Eur J Cancer, 40(16): 2424-31. [Abstract] [Full-text]
23. Use of extracorporeal membrane oxygenation (ECMO) during whole lung lavage in pulmonary alveolar proteinosis associated with lung cancer.
    Eur J Cardiothorac Surg, 26(5): 1050-1. [Abstract] [Full-text]
24. A combined small cell carcinoma of the lung containing three components: small cell, spindle cell and squamous cell carcinoma.
    Eur J Cardiothorac Surg, 26(5): 1047-9. [Abstract] [Full-text]
25. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    J Natl Cancer Inst, 96(21): 1593-603. [Abstract] [Full-text]
26. Video-assisted thoracoscopic resection of pulmonary lesions.
    Eur J Surg Oncol, 30(10): 1118-22. [Abstract] [Full-text]
27. Completion pneumonectomy for lung metastases.
    Eur J Surg Oncol, 30(10): 1113-7. [Abstract] [Full-text]
28. Depletion of activated Vbeta8+ T cells disrupts bispecific antibody directed antitumor immunity.
    J Surg Res, 122(1): 103-12. [Abstract] [Full-text]
29. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    J Surg Res, 122(1): 61-9. [Abstract] [Full-text]
30. Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.
    Cancer Chemother Pharmacol, 54(6): 573-7. [Abstract] [Full-text]
31. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
    Oncogene, 23(52): 8439-46. [Abstract] [Full-text]
32. Parathyroid hormone-related protein regulates apoptosis in lung cancer cells through protein kinase A.
    Am J Physiol Cell Physiol, 287(6): C1616-22. [Abstract] [Full-text]
33. Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status.
    Invest New Drugs, 23(1): 73-7. [Abstract] [Full-text]
34. An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin.
    Invest New Drugs, 23(1): 63-71. [Abstract] [Full-text]
35. Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98).
    Invest New Drugs, 23(1): 51-6. [Abstract] [Full-text]
36. Action of solamargine on human lung cancer cells--enhancement of the susceptibility of cancer cells to TNFs.
    FEBS Lett, 577(1): 67-74. [Abstract] [Full-text]
37. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
    Cancer Gene Ther, 11(11): 733-9. [Abstract] [Full-text]
38. Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.
    J Endocrinol, 183(2): 375-83. [Abstract] [Full-text]
39. Diagnosis of metastatic carcinoma to the cavernous sinus by computed tomograpy-guided fine-needle aspiration.
    Am J Ophthalmol, 138(5): 864-6. [Abstract] [Full-text]
40. The feasibility of low-dose CT for pulmonary metastasis in patients with primary gynecologic malignancy.
    Clin Imaging, 28(6): 408-14. [Abstract] [Full-text]
41. Protective effect of piperine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice.
    Clin Chim Acta, 350(1): 73-8. [Abstract] [Full-text]
42. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Cancer, 101(10): 2318-26. [Abstract] [Full-text]
43. Decision making in a multidisciplinary cancer team: does team discussion result in better quality decisions?
    Med Decis Making, 24(6): 602-13. [Abstract] [Full-text]
44. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Clin Cancer Res, 10(21): 7382-91. [Abstract] [Full-text]
45. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Clin Cancer Res, 10(21): 7318-28. [Abstract] [Full-text]
46. Dominant papillary subtype is a significant predictor of the response to gefitinib in adenocarcinoma of the lung.
    Clin Cancer Res, 10(21): 7311-7. [Abstract] [Full-text]
47. Sarcomatoid carcinoma with components of small cell carcinoma and undifferentiated carcinoma of the gallbladder.
    Pathol Int, 54(11): 866-71. [Abstract] [Full-text]
48. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.
    Am J Respir Crit Care Med, 170(10): 1088-94. [Abstract] [Full-text]
49. Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma.
    Proteomics, 4(11): 3394-400. [Abstract] [Full-text]
50. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer.
    Oncogene, 23(53): 8695-9. [Abstract] [Full-text]
51. Ultrathin bronchoscopic barium marking with virtual bronchoscopic navigation for fluoroscopy-assisted thoracoscopic surgery.
    Chest, 126(5): 1687-93. [Abstract] [Full-text]
52. Why do physicians who treat lung cancer get sued?
    Chest, 126(5): 1672-9. [Abstract] [Full-text]
53. Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer.
    Chest, 126(5): 1656-66. [Abstract] [Full-text]
54. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Chest, 126(5): 1529-39. [Abstract] [Full-text]
55. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
    J Clin Oncol, 22(22): 4575-83. [Abstract] [Full-text]
56. Relationship of shuttle walk test and lung cancer surgical outcome.
    Eur J Cardiothorac Surg, 26(6): 1216-9. [Abstract] [Full-text]
57. Lung adenocarcinoma can be subtyped according to tumor dimension by computed tomography mediastinal-window setting. Additional size criteria for clinical T1 adenocarcinoma.
    Eur J Cardiothorac Surg, 26(6): 1211-5. [Abstract] [Full-text]
58. Resection of chest wall invasion in patients with non-small cell lung cancer.
    Eur J Cardiothorac Surg, 26(6): 1200-4. [Abstract] [Full-text]
59. Bronchoplastic procedures for central carcinoid tumors: clinical experience.
    Eur J Cardiothorac Surg, 26(6): 1196-9. [Abstract] [Full-text]
60. Epithelial-directed drug delivery: influence of formulation and delivery devices.
    Lung Cancer, 46(3): 387-92. [Abstract] [Full-text]
61. Carcinoma in situ from the view of complete resection.
    Lung Cancer, 46(3): 383-5. [Abstract] [Full-text]
62. Results of a Phase II study of carboplatin plus gemcitabine in patients with untreated extensive small cell lung cancer.
    Lung Cancer, 46(3): 369-75. [Abstract] [Full-text]
63. Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.
    Lung Cancer, 46(3): 361-8. [Abstract] [Full-text]
64. Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer.
    Lung Cancer, 46(3): 357-60. [Abstract] [Full-text]
65. Pit-fall sign on computed tomography predicts pleural involvement and poor prognosis in non-small cell lung cancer.
    Lung Cancer, 46(3): 349-55. [Abstract] [Full-text]
66. Synchronous lesions detected by autofluorescence bronchoscopy in patients with high-grade preinvasive lesions and occult invasive squamous cell carcinoma of the proximal airways.
    Lung Cancer, 46(3): 341-7. [Abstract] [Full-text]
67. High serum YKL-40 level in patients with small cell lung cancer is related to early death.
    Lung Cancer, 46(3): 333-40. [Abstract] [Full-text]
68. Prognostic value of tumor size in non-small cell lung cancer larger than five centimeters in diameter.
    Lung Cancer, 46(3): 325-31. [Abstract] [Full-text]
69. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
    Lung Cancer, 46(3): 313-23. [Abstract] [Full-text]
70. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.
    Lung Cancer, 46(3): 305-12. [Abstract] [Full-text]
71. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Lung Cancer, 46(3): 299-304. [Abstract] [Full-text]
72. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer.
    Lung Cancer, 46(3): 293-8. [Abstract] [Full-text]
73. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
    Lung Cancer, 46(3): 283-91. [Abstract] [Full-text]
74. Molecular analysis of the TSC1 gene in adenocarcinoma of the lung.
    Lung Cancer, 46(3): 271-81. [Abstract] [Full-text]
75. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan.
    Lung Cancer, 46(3): 265-70. [Abstract] [Full-text]
76. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.
    J Clin Oncol, 22(22): 4456-62. [Abstract] [Full-text]
77. Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials.
    Ann Oncol, 15(12): 1782-9. [Abstract] [Full-text]
78. Clear cell sarcoma associated with multiple pulmonary metastases with structural and numerical karyotypic changes.
    Clin Exp Dermatol, 29(6): 614-6. [Abstract] [Full-text]
79. Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer.
    J Natl Cancer Inst, 96(22): 1718-21. [Abstract] [Full-text]
80. Paraneoplastic leukocytosis with mature neutrophilia in a cat with pulmonary squamous cell carcinoma.
    J Feline Med Surg, 6(6): 391-5. [Abstract] [Full-text]
81. Survival after resection for lung cancer is the outcome that matters.
    Am J Surg, 188(5): 598-602. [Abstract] [Full-text]
82. Complications and long-term survival for alcoholic patients with resectable lung cancer.
    Am J Surg, 188(5): 553-9. [Abstract] [Full-text]
83. Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses.
    Tissue Antigens, 64(6): 650-9. [Abstract] [Full-text]
84. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate.
    Health Psychol, 23(6): 564-73. [Abstract] [Full-text]
85. The fine-needle aspiration biopsy cytology of pancreatoblastoma.
    Diagn Cytopathol, 31(6): 402-6. [Abstract] [Full-text]
86. Selenophosphate synthetase genes from lung adenocarcinoma cells: Sps1 for recycling L-selenocysteine and Sps2 for selenite assimilation.
    Proc Natl Acad Sci U S A, 101(46): 16162-7. [Abstract] [Full-text]
87. Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis.
    J Histochem Cytochem, 52(12): 1537-42. [Abstract] [Full-text]
88. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Hum Immunol, 65(11): 1377-88. [Abstract] [Full-text]
89. The relationship between solitary pulmonary nodules and bronchi: multi-slice CT-pathological correlation.
    Clin Radiol, 59(12): 1121-7. [Abstract] [Full-text]
90. Patterns of metastatic breast carcinoma: influence of tumour histological grade.
    Clin Radiol, 59(12): 1094-8. [Abstract] [Full-text]
91. Endoscopic ultrasound and staging of non-small cell lung cancer.
    Gastrointest Endosc Clin N Am, 15(1): 157-67, x. [Abstract] [Full-text]
92. Metachronous and synchronous lung tumors: five malignant lung pathologies in 1 patient during 7 years.
    Ann Thorac Surg, 78(6): 2154-5. [Abstract] [Full-text]
93. Clinicopathological analysis of pulmonary sclerosing hemangioma.
    Ann Thorac Surg, 78(6): 1928-31. [Abstract] [Full-text]
94. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.
    Ann Thorac Surg, 78(6): 1919-26; discussion 1926-7. [Abstract] [Full-text]
95. Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary?
    Ann Thorac Surg, 78(6): 1910-6; discussion 1916-8. [Abstract] [Full-text]
96. Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer.
    Ann Thorac Surg, 78(6): 1903-9; discussion 1909. [Abstract] [Full-text]
97. Characterization of the B2 receptor and activity of bradykinin analogs in SHP-77 cell line by Cytosensor microphysiometer.
    Chem Biol Interact, 150(3): 283-93. [Abstract] [Full-text]
98. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Br J Cancer, 91(11): 1970-6. [Abstract] [Full-text]
99. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    J Biol Chem, 279(49): 51630-46. [Abstract] [Full-text]
100. Systemic melanoma metastatic to the retina and vitreous.
     Ophthalmologica, 218(6): 424-33. [Abstract] [Full-text]
101. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.
     Radiology, 233(3): 793-8. [Abstract] [Full-text]
102. Detection of lung cancer on radiographs: receiver operating characteristic analyses of radiologists', pulmonologists', and anesthesiologists' performance.
     Radiology, 233(3): 799-805. [Abstract] [Full-text]
103. Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan.
     Int J Cancer, 113(3): 440-5. [Abstract] [Full-text]
104. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues.
     Int J Cancer, 113(3): 359-63. [Abstract] [Full-text]
105. Phase I study of green tea extract in patients with advanced lung cancer.
     Cancer Chemother Pharmacol, 55(1): 33-8. [Abstract] [Full-text]
106. Biological responses of workplace particles and their association with adverse health effects on miners.
     J Environ Monit, 6(12): 967-72. [Abstract] [Full-text]
107. Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model.
     Biochem Biophys Res Commun, 326(1): 210-7. [Abstract] [Full-text]
108. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
     J Clin Oncol, 22(23): 4837-45. [Abstract] [Full-text]
109. Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.
     Clin Cancer Res, 10(22): 7662-70. [Abstract] [Full-text]
110. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
     Clin Cancer Res, 10(22): 7655-61. [Abstract] [Full-text]
111. Relationship between micropapillary component and micrometastasis in the regional lymph nodes of patients with stage I lung adenocarcinoma.
     Histopathology, 45(6): 580-6. [Abstract] [Full-text]
112. Diagnosis of lung cancer in primary care: a structured review.
     Fam Pract, 21(6): 605-11. [Abstract] [Full-text]

© 2004-2010 Lung Cancer Research Today. All Rights Reserved.